文献速递关节外科创伤骨科

假体周围关节感染与翻修全膝关节置换术后静脉血栓栓塞风险增加相关:基于行政出院数据的分析

Periprosthetic Joint Infection Is Associated with an Increased Risk of Venous Thromboembolism Following Revision Total Knee Replacement: An Analysis of Administrative Discharge Data.
PubMed 文献 · J Bone Joint Surg Am · 2021-01-01

基于纽约州1998至2014年行政出院数据,纳入25,441例翻修全膝关节置换患者,评估术后90天静脉血栓栓塞(VTE)风险。感染翻修者90天VTE发生率为4.3%,无菌翻修为2.1%,骨折翻修为5.9%;感染翻修相对无菌翻修的VTE调整比值比为2.01(95%CI 1.72-2.35),骨折翻修为2.62(95%CI 1.91-3.6)。结论提示翻修指征应纳入术后VTE预防选择。

要点

  • 感染翻修全膝关节置换术后90天VTE风险是无菌翻修的2倍(aOR 2.01)。
  • 骨折翻修术后VTE风险是无菌翻修的2.62倍,尽管骨折仅占翻修指征的3%。
  • 既往VTE史也是翻修术后VTE的强危险因素(aOR 2.01)。

核心结论

  • 感染翻修全膝关节置换术后VTE的 odds 是无菌翻修的2倍。
  • 骨折翻修术后VTE风险是无菌翻修的2.6倍,尽管骨折仅占翻修的小部分。
  • 选择术后VTE预防时应考虑翻修全膝关节置换的指征。

研究设计与样本

  • 回顾性队列研究,使用纽约州 statewide 规划与研究合作系统数据,纳入1998至2014年所有接受翻修全膝关节置换的纽约州居民,共25,441例。
  • 采用ICD-9-CM编码识别合并症并将翻修指征分类为无菌、感染或骨折。
  • 主要结局为翻修手术和/或随后90天内住院记录的任何VTE诊断编码。
  • 使用多变量logistic回归模型(纳入人口学特征和合并症)估计感染或骨折翻修相对无菌翻修的VTE风险。
  • 证据等级为预后Level III。

主要发现

  • 共纳入25,441例翻修全膝关节置换患者,平均年龄66±12岁,女性15,592例(61%),黑人3,198例(13%),吸烟者1,192例(5%),肥胖者4,222例(17%)。
  • 翻修指征:无菌17,563例(69%),感染7,075例(28%),骨折803例(3%)。
  • 90天VTE发生率:无菌翻修2.1%,感染翻修4.3%,骨折翻修5.9%。
  • 相对无菌翻修,感染翻修的VTE调整比值比(aOR)为2.01(95%CI 1.72-2.35),骨折翻修为2.62(95%CI 1.91-3.6);既往VTE史aOR为2.01(95%CI 1.48-2.71)。

临床怎么用

  • 对于因感染或骨折行翻修全膝关节置换的患者,应意识到术后90天VTE风险显著高于无菌翻修。
  • 选择术后VTE预防方案时,应将翻修指征(感染、骨折)以及既往VTE史纳入考量。

局限性

  • 基于行政出院数据,依赖ICD-9-CM编码识别VTE、合并症和翻修指征,可能存在编码偏倚或漏诊。
  • 无法获取原文未报告的临床细节(如具体预防措施、实验室指标、影像学确认等)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the relationship between infection and the risk of risk of venous thromboembolism (VTE) following orthopaedic surgery. We assessed the 90-day risk of VTE following revision total knee replacement to measure the association between periprosthetic joint infection and the risk of postoperative VTE. METHODS: We used New York Statewide Planning and Research Cooperative System data to identify all New York State residents undergoing revision total knee replacement from 1998 to 2014. ICD-9-CM (International Classification of Diseases, Ninth Revision, Clinical Modification) codes were used to identify comorbidities and to classify the indication for revision total knee replacement as aseptic, infection, or fracture. The primary outcome was any diagnosis code for VTE recorded for the revision surgery and/or subsequent admissions within 90 days. A multivariable logistic regression model that included demographic characteristics and comorbidities was used to estimate the risk of VTE after revision for infection or fracture, with aseptic revision as the reference group. RESULTS: The present study included 25,441 patients who were managed with revision total knee replacement; the indication for revision was aseptic for 17,563 patients (69%), infection for 7,075 (28%), and fracture for 803 (3%). The mean age (and standard deviation) was 66 ± 12 years, 15,592 (61%) of the patients were female, 3,198 (13%) were Black, 1,192 (5%) were smokers, and 4,222 (17%) were obese. Seven hundred and nineteen patients (2.8%) had VTE within the 90 days after revision total knee replacement, including 387 (1.5%) during the admission for the revision procedure. The 90-day incidence of VTE was 2.1% after aseptic revision, 4.3% after revision for infection, and 5.9% after revision for fracture. The adjusted odds ratio (aOR) for VTE relative to aseptic revision was 2.01 (95% confidence interval [CI], 1.72 to 2.35) for septic revision total knee replacement and 2.62 (95% CI, 1.91 to 3.6) for fracture. A history of VTE was also a strong risk factor for VTE following revision total knee replacement (aOR, 2.01; 95% CI, 1.48 to 2.71). CONCLUSIONS: We found that the odds of VTE after revision total knee replacement for infection were double those after aseptic revision total knee replacement. Although fracture accounts for a small percentage of revision total knee replacements, the risk of VTE was 2.6-fold higher after these procedures. The indication for revision total knee replacement should be considered when choosing postoperative VTE prophylaxis. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Bass AR, Zhang Y, Mehta B, et al. Periprosthetic Joint Infection Is Associated with an Increased Risk of Venous Thromboembolism Following Revision Total Knee Replacement: An Analysis of Administrative Discharge Data. J Bone Joint Surg Am. 2021. PMID: 33750744. doi:10.2106/JBJS.20.01486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。